Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer Tianqian ZhangDorothee Herlyn Review 17 October 2008 Pages: 475 - 492
Intravesical administration of γδ T cells successfully prevents the growth of bladder cancer in the murine model Takeshi YuasaKiyoshi SatoShinya Kimura Original Article 06 August 2008 Pages: 493 - 502
Antigen-presenting cells containing multiple costimulatory molecules promote activation and expansion of human antigen-specific memory CD8+ T cells Sixun YangJeffrey Schlom Original Article 09 August 2008 Pages: 503 - 515
Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma Robin GoforthAliasger K. SalemAnthony D. Sandler Original Article 22 August 2008 Pages: 517 - 530
Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor Mariangela FiginiFranck MartinSilvana Canevari Original Article 15 August 2008 Pages: 531 - 546
Early developmental expression of a normally tumor-associated and drug-inhibited cell surface-located NADH oxidase (ENOX2) in non-cancer cells NaMi ChoD. James Morré Original Article 15 August 2008 Pages: 547 - 552
A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes Régis BouquiéAnnabelle BonninFrançois Lang Original Article 27 August 2008 Pages: 553 - 566
Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells Irina L. TourkovaGalina V. ShurinMichael R. Shurin Original Article 28 August 2008 Pages: 567 - 574
NK1.1+ cells mediate the antitumor effects of a dual Toll-like receptor 7/8 agonist in the disseminated B16-F10 melanoma model Calin D. DumitruMary A. AntonysamyGary W. Gullikson Original Article 13 September 2008 Pages: 575 - 587
Treatment of ovarian cancer cell lines with 5-aza-2′-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules Sara J. AdairKevin T. Hogan Original Article 13 September 2008 Pages: 589 - 601
High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells Michaël HerfsLudivine HermanPhilippe Delvenne Original Article 19 September 2008 Pages: 603 - 614
Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse Alain P. VicariRachel LuuArthur M. Krieg Original Article 19 September 2008 Pages: 615 - 628
In vivo anti-melanoma efficacy of allo-restricted CTLs specific for melanoma expanded by artificial antigen-presenting cells Xiao-ling LuXiao-bing JiangSheng-min Zhang Original Article 06 August 2008 Pages: 629 - 638
In vivo anti-melanoma efficacy of allo-restricted CTLs specific for melanoma expanded by artificial antigen-presenting cells Xiao-ling LuXiao-bing JiangZhi-hui Liang Erratum 17 October 2008 Pages: 639 - 639